Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-21-057730
Filing Date
2021-04-29
Accepted
2021-04-29 17:00:33
Documents
3
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tm2113339d1_10ka.htm 10-K/A 305205
2 EXHIBIT 31.3 tm2113339d1_ex31-3.htm EX-31.3 3647
3 EXHIBIT 31.4 tm2113339d1_ex31-4.htm EX-31.4 3723
  Complete submission text file 0001104659-21-057730.txt   313673
Mailing Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE, SUITE 300 NEW YORK NY 10170 (212) 479-2513
Scopus BioPharma Inc. (Filer) CIK: 0001772028 (see all company filings)

EIN.: 821248020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39788 | Film No.: 21871763
SIC: 2834 Pharmaceutical Preparations